Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization

Annals of Surgical Oncology

Volumn 10, Issue 3, 2003, Pages 242-247

  Simmons, Rache ^a,c   Thevarajah, Sarmela ^a   Brennan, Meghan B ^a   Christos, Paul ^b   Osborne, Michael ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NONE   (United States)

Author keywords

Breast cancer; Isosulfan blue; Methylene blue; Sentinel lymph node biopsy; Sentinel node

Indexed keywords

EOSIN; HEMATOXYLIN; ISOSULFAN BLUE; METHYLENE BLUE; TECHNETIUM SULFUR COLLOID TC 99M; DIAGNOSTIC AGENT; ENZYME INHIBITOR; FUCHSINE; ISO SULFAN BLUE; ISO-SULFAN BLUE;

ACCURACY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER PATIENT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL RECORD; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; FEMALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; ENZYME INHIBITORS; FEMALE; HUMANS; LYMPHATIC METASTASIS; METHYLENE BLUE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0038809964     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.04.021     Document Type: Article

References (28)

1. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469-74.
2. Medina-Franco H, Beenken SW, Heslin MJ, Urist MM. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol 2001;8:716-9.
3. Link EM, Costa DC, Lane D, Blower PJ, Spittle MF. Radioiodinated methylene blue for diagnosing early melanoma metastases. Lancet 1996;348:753.
4. Landra M, Acchiardi F, Pugno F, Forte G, Granetto C, Camuzzini GF. Sentinel node mapping for malignant melanoma. Tumori 2000;86:354-5.
5. Fukui Y, Yamakawa T, Taniki T, Numoto S, Miki H, Monden Y. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001;92:2868-74.
6. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 1999;52:922-4.
7. Weaver DL, Krag DN, Ashikaga T, et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000;88:1099-107.
8. Simmons RM, Smith SMR, Osborne MP. Methylene blue as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J 2001;7:181-3.
9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
10. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Cancer Soc 1998;186:423-7.
11. Bass SS, Cox CE, Ku NN, Berman C, Reintgen DS. The role of sentinel node biopsy in breast cancer. J Am Cancer Soc 1999;189: 183-94.
12. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
13. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;93:473-8.
14. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-6.
15. Tafra LC, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-9.
16. Tanis PJ, Deurloo EE, Valdes Olmos RA, et al. Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol 2001;8:850-5.
17. Linehan DC, Hill ADK, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 1999;6: 450-4.
18. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
19. Koller M, Barsuk D, Zippel D, Engelberg S, Ben-Ari G, Papa MZ. Sentinel lymph node involvement: a predictor for axillary node status with breast cancer - has the time come? Eur J Surg Oncol 1998;24:166-8.
20. Borgstein PJ, Pijper R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Cancer Soc 1998;186:275-83.
21. Hsueh EC, Turner RR, Glass EC, Brenner RJ, Brennan M, Giuliano AE. Sentinel node biopsy in breast cancer. J Am Cancer Soc 1999;189:207-13.
22. Gann PH, Colilla SA, Gapstur SM, et al. Factors associated with axillary lymph node metastasis from breast cancer: descriptive and predictive analyses. Cancer 1999;86:1511-9.
23. Chao C, Wong SL, Ackermann D, et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg 2001;182:609-15.
24. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-8.
25. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery 2001;130:439-42.
26. Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm 1995;4:219-21.
27. Leong SP, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361-6.
28. Laurie SA, Khan DA, Gruchalla RS, Peters G. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 2002;88:64-6.